Researchers from Eindhoven University of Technology and the Catharina Hospital in Eindhoven have developed a new algorithm for the rapid screening for COVID-19. The software is intended for use in Emergency Rooms, to quickly exclude the presence of corona in incoming patients. As a result, doctors need to conduct fewer standard coronavirus tests, increasing efficiency. The quick scan for COVID-19 was developed within three months and is already being used by doctors in the Emergency Room (ER) of the Catharina Hospital. At the peak of the coronary pandemic, ER doctors at the Catharina Hospital approached the researchers asking whether they knew of any tests for COVID-19 that were faster than the standard PCR test.
The Polish financial supervisor (KNF), as one of the first countries in the European Union, developed a position on robo-advice. Such activities support the use of artificial intelligence in the process of investment advisory services. While robotization reduces costs and increases efficiency, appropriate regulations are necessary. One of the challenges is to legally secure liability for damages that may arise in connection with the use of artificial intelligence. "Even 10 years ago, when driving with navigation and with a passenger, when the navigation said'go straight', and someone sitting next to him said'take a turn', we would have turned. We didn't believe the technology was good enough. Today we will go straight. It is similar with artificial intelligence in the field of consulting. Today we will choose a human being because we believe that technology in this area is not good enough yet. In 10 years, we may choose a robotic advisor," Jakub Szpringer, a partner at KSZ Smart Legal - Karwasiński Szpringer i Wspólnicy, said.
Scientists have warned there could be thousands of excess deaths in the UK in the coming years due to delays in cancer diagnosis and treatment during by the coronavirus crisis. The pandemic has meant routine screenings, and urgent referrals and treatments, have been delayed or cancelled, leading to a backlog of patients. Researchers at the Health Data Research Hub for Cancer examined data from eight hospital trusts and found that, in a worst-case scenario, if delays continue, there could be up to 35,000 additional cancer deaths within a year. But artificial intelligence (AI) could be a solution. Over the past decade, AI has emerged as a leading technology with the potential to aid the medical community, from speeding up diagnostics and improving accuracy to improving patient outcomes and hospital efficiencies.
Artificial Intelligence and Machine Learning are important components in helping enterprises maintain organisational resilience and detect cyberthreats. Asher De Metz, Lead Senior Consultant at Sungard AS, discusses the benefits of using this technology to become more cyber-aware. The COVID-19 pandemic continues to be an immense humanitarian crisis that is severely impacting the global economy. As organisations have shifted to remote working to protect employees while continuing to serve customers, they have moved the majority of activities to the digital world – increasing the risk of cyberattacks and threatening Business Continuity. According to the World Economic Forum's COVID-19 risks outlook, employers are most worried about COVID-19 provoking a prolonged recession, followed by a surge in bankruptcies.
Medical researchers are employing AI to search through databases of known drugs to see if any can be associated with a treatment for the new COVID-19 coronavirus. An early success story comes from BenevolentAI of London, which using tools developed to search through medical literature, identified rheumatoid arthritis drug baricitinib as a possible treatment for COVID-19. In a pilot study at the end of March, 12 adults with moderate COVID-19 admitted to the hospital in either Alessandria or Prato, Italy, received a daily dose of baricitinib, along with an anti-HIV drug combination of lopinavir and ritonavir, for two weeks. Another study group of 12 received just lopinavir and ritonavir. After their two-week treatment, the patients who received baricitinib had mostly recovered, according to a recent account in The Scientist.
Pixabay – Martin Büdenbender Researchers from the Eindhoven University of Technology and the Catharina Hospital in Eindhoven have developed a new algorithm for rapid screening of COVID-19. The software is intended for use in Emergency Rooms, to quickly exclude the presence of corona in incoming patients. As a result, doctors need to conduct fewer standard coronavirus tests, increasing efficiency. The quick scan for COVID-19 was developed within three months and is already in use by doctors in the Emergency Room (ER) of the Catharina Hospital.
For the third straight year, Deloitte surveyed executives about their companies' sentiments and practices regarding AI technologies. We were particularly interested in understanding what it will take to stay ahead of the pack as AI adoption grows--and we wanted to learn how adopters are managing risk around the technologies as AI governance, trust, and ethics become more of a boardroom issue. Get the Deloitte Insights app. Adopters continue to have confidence in AI technologies' ability to drive value and advantage. We see increasing levels of AI technology implementation and financial investment. Adopters say they are realizing competitive advantage and expect AI-powered transformation to happen for both their organization and industry. Early-mover advantage may fade soon. As adoption becomes ubiquitous, AI-powered organizations may have to work harder to maintain an edge over their industry peers.